Mark Clein
Co-Founder and Chief Executive Officer
Precision Medicine Group
Mark Clein
Co-Founder and Chief Executive Officer, Precision Medicine Group
Healthcare entrepreneur and co-founder of industry-leading ventures—including United BioSource Corporation (UBC), a leader in real-world research addressing safety, value, and comparative effectiveness for the life sciences industry, and US Bioservices, a provider of personalized, direct-to-patient distribution services for specialty pharmaceuticals and biologics. Mark was CEO of PMR Corporation, a leading provider of outpatient services for psychiatric and central nervous system disorders. He serves on the Board of Councilors for USC’s School of Pharmacy and holds an MBA from Columbia Graduate School of Business and a BA from the University of North Carolina.